Ushbu ish iqtibos qilgan ishlar

111 ta ish

Ish: The microbiome and precision oncology: an emerging paradigm in anticancer therapy

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67
Maqola20176 iqtibos
ABI
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45
Maqola20175 iqtibos
ABI
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo González, Catharina Hagerling, Zena Werb
Sharh maqola20184 iqtibos
ABI
The Human Microbiome Project
Peter J. Turnbaugh, Ruth E. Ley, Micah Hamady +3
Maqola20073 iqtibos
ABI
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
Haoyi Wang, Hui Yang, Chikdu Shivalila +4
Maqola20133 iqtibos
ABI
Human papillomavirus and cervical cancer
Mark Schiffman, Philip E. Castle, José Jerónimo +2
Sharh maqola20073 iqtibos
ABI
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vétizou, Jonathan M. Pitt, Romain Daillère +35
Maqola20153 iqtibos
ABI
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Ron Sender, Shai Fuchs, Ron Milo
Maqola20163 iqtibos
ABI
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
Vyara Matson, Jessica Fessler, Riyue Bao +5
Maqola20183 iqtibos
ABI
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Bret D. Wallace, Hongwei Wang, Kimberly T. Lane +8
Maqola20103 iqtibos
ABI
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillère, Marie Vétizou, Nadine Waldschmitt +33
Maqola20163 iqtibos
ABI
Cancer statistics, 2020
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal
Maqola20203 iqtibos
ABI
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Sandra Demaria, Bruce Ng, M. Devitt +4
Maqola20042 iqtibos
ABI
The future of immune checkpoint therapy
Padmanee Sharma, James P. Allison
Sharh maqola20152 iqtibos
ABI
Gut biogeography of the bacterial microbiota
Gregory P. Donaldson, S. Melanie Lee, Sarkis K. Mazmanian
Sharh maqola20152 iqtibos
ABI
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Leonard B. Saltz, John V. Cox, Charles D. Blanke +9
Maqola20002 iqtibos
ABI
Doxorubicin: The Good, the Bad and the Ugly Effect
Cristina Carvalho, Renato X. Santos, Susana Cardoso +4
Sharh maqola20092 iqtibos
ABI
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud, Fabiana Saccheri, Grégoire Mignot +30
Maqola20132 iqtibos
ABI
Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Ayelet Sivan, Leticia Corrales, Nathaniel Hubert +9
Maqola20152 iqtibos
ABI
Anticancer effects of the microbiome and its products
Laurence Zitvogel, Romain Daillère, María Paula Roberti +2
Sharh maqola20172 iqtibos
ABI
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma, David Miles, Luca Gianni +11
Maqola20122 iqtibos
ABI
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Deborah Nejman, Ilana Livyatan, Garold Fuks +58
Maqola20202 iqtibos
ABI
Tumor-Associated Microbiome: Where Do We Stand?
Marc Oliva, Núria Mulet-Margalef, María Ochoa-de-Olza +7
Sharh maqola20212 iqtibos
ABI
Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
Yao He, Liuhui Fu, Yiping Li +10
Maqola20212 iqtibos
ABI
Bacterial infection as a cause of cancer.
Julie Parsonnet
Sharh maqola19952 iqtibos
ABI